Physician profile
Mark D Noel
NPI 1396935920
$1,647.42
in general payments reported to CMS, 2019-2025
11 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $49.10 · 2021: $14.61 · 2023: $101 · 2024: $1,005 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Travel and Lodging: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.52 |
| Travel and Lodging | $419.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,284.91 | 2023-2025 | Inspire |
| Medtronic, INC. | $85.97 | 2024 | Pteye Parathyroid Detection System |
| Acclarent, INC | $84.75 | 2019 | |
| Medtronic USA, INC. | $49.10 | 2020 | |
| Tactile Systems Technology INC | $45.38 | 2025 | Nimbl, Flexitouch Plus |
| Genzyme Corporation | $18.87 | 2019 | |
| Aerin Medical INC. | $17.49 | 2019 | |
| Stryker Corporation | $17.34 | 2025 | Scopis Ent |
| Intersect Ent, INC. | $14.78 | 2019 | |
| Olympus America INC. | $14.61 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.